拱墙
发表于 2025-3-23 09:49:10
http://reply.papertrans.cn/19/1829/182854/182854_11.png
遭遇
发表于 2025-3-23 17:36:39
http://reply.papertrans.cn/19/1829/182854/182854_12.png
Chipmunk
发表于 2025-3-23 21:35:10
http://reply.papertrans.cn/19/1829/182854/182854_13.png
Integrate
发表于 2025-3-24 01:58:44
http://reply.papertrans.cn/19/1829/182854/182854_14.png
怪物
发表于 2025-3-24 02:26:02
Metabotropic Glutamate Receptors: Their Therapeutic Potential in Anxiety,
使无效
发表于 2025-3-24 07:36:23
http://reply.papertrans.cn/19/1829/182854/182854_16.png
印第安人
发表于 2025-3-24 12:09:48
Pharmacological Treatment of Generalized Anxiety Disorder,
Parley
发表于 2025-3-24 15:21:59
http://reply.papertrans.cn/19/1829/182854/182854_18.png
nephritis
发表于 2025-3-24 19:25:26
1866-3370 y disorders by Ron Kessler and colleagues, which provides an authoritative survey of anxiety disorder incidence, prevalence, and risk factors. This is comp- mented by a comprehensive review of 978-3-642-26375-0978-3-642-02912-7Series ISSN 1866-3370 Series E-ISSN 1866-3389
insidious
发表于 2025-3-24 23:21:19
1866-3370 and its treatment. We have brought together a distinguished cadre of authors with the aim of covering a broad array of topics related to anxiety disorders, ranging from clinical diagnosis, epidemiology, preclinical neuroscience, and animal models to established and innovative therapeutic approaches.